Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-09

Clinical Trial Update: Effectiveness and Safety of ONUREG (Oral Azacitidine) in Chinese Patients With Acute Myeloid Leukemia

View source ↗

Summary

This clinical trial update reports on the effectiveness and safety of ONUREG (oral azacitidine) in Chinese patients with acute myeloid leukemia. The study is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Onureg (azacitidine)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Acute Myeloid Leukemia (AML) | Status: ACTIVE_NOT_RECRUITING